CORT
Corcept Therapeutics Incorporated
NASDAQ: CORT · HEALTHCARE · BIOTECHNOLOGY
$46.59
-0.06% today
Updated 2026-04-29
Market cap
$5.00B
P/E ratio
56.82
P/S ratio
6.57x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$29 – $91
Volume
1.8M
Corcept Therapeutics Incorporated (CORT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$46.59
12-Month target
$24.55
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.4B | $0.4B | $0.5B | $0.7B | $0.8B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 13.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.